BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
ZBTB7A
,
T cell receptor signaling pathway
,
Leukemia
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mitotic anaphase
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lung adenocarcinoma stage I, II, and II and healthy lung tissue
Retinal pigment epithelial RPE-1 cells; role of translational repression in M-phase entry
Thymocytes from Prkdc mutant, Tlx1 expressing mice sorted for double negative (DN) stages
Explore Curated Studies Results
Literature
Most Relevant Literature
Relocation of the chromosomal passenger complex prevents mitotic checkpoint engagement at anaphase.
Mitotic regulation of the anaphase-promoting complex.
An in vitro assay for Cdc20-dependent mitotic anaphase-promoting complex activity from budding yeast…
A Wee1 checkpoint inhibits anaphase onset.
Cdc48 is required for the stability of Cut1/separase in mitotic anaphase.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ